Stay updated on Cabozantinib-Pemetrexed in Lung, Urothelial, Mesothelioma Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib-Pemetrexed in Lung, Urothelial, Mesothelioma Clinical Trial page.

Latest updates to the Cabozantinib-Pemetrexed in Lung, Urothelial, Mesothelioma Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedPage revision updated to v3.5.0, replacing the previous v3.4.3.SummaryDifference0.1%

- Check22 days agoChange DetectedRevision label updated to v3.4.3, replacing the previous v3.4.2.SummaryDifference0.1%

- Check51 days agoChange DetectedSite revision updated to Revision: v3.4.2, and the previous government funding status notice (v3.4.1) was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check58 days agoChange DetectedA site-wide notice about a lapse in government funding and the NIH Clinical Center's operating status was added. The page version was updated from v3.4.0 to v3.4.1.SummaryDifference0.5%

- Check65 days agoChange DetectedUI and metadata updates include displaying the glossary toggle, updating the 'Last Update Submitted that Met QC Criteria' label, minor wording changes for 'No FEAR Act Data', and the site revision note v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check79 days agoChange DetectedThe page now displays Revision: v3.3.4, replacing the previous v3.3.3. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Cabozantinib-Pemetrexed in Lung, Urothelial, Mesothelioma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib-Pemetrexed in Lung, Urothelial, Mesothelioma Clinical Trial page.